It is a paradox that medical experimentation on individuals, whetherpatients or healthy volunteers, is now controlled by strict ethical guidelines, while no such protection existsfor wholepopulations which are subjected to medical interventions in the name ofpreventive medicine or health promotion. As many such interventions are either ofdubious benefit or ofuncertain harm-benefit balance, such as mass screeningfor cancers orfor risk factors associated with coronary heart disease, there is no justification for maintaining the ethical vacuum in which preventive medicine finds itselfat present.
Ethics of human experimentation
History shows that the medical profession seldom puts its house in order unless under pressure from the public. It may not be generally appreciated that ethical guidelines governing human experimentation were never part of the medical code until public revulsion at scandalous experiments on human 'guinea-pigs' in the 1950s and 1960s which were sponsored by official medical bodies (1) (2) (3) (4) (5) . Research ethics committees owe their existence to public concern, such as that which followed exposure of the Tuskegee experiment, conducted by the US Public Health Service and the Surgeon-General on some 400 poor blacks whose syphilis had been left untreated in order to study the natural progression of the disease. The patients' (ifthat is the word) co-operation was obtained by the promise ofa free funeral. The study was not stopped until 1972, not because the medical profession protested when they saw interim reports from this study in medical journals, but because a non-medical assistant leaked the details of the experiment to a reporter from the Associated Press (1). The subsequent Senate hearing resulted in the National Research Act, 1974, which contained specific provision for 'institutional review boards', that is ethical committees (6 Tunkel , who is a barrister, a patient who takes part in a trial and suffers adverse effects has no legal right to compensation and should be informed beforehand accordingly (9) .
There is no reason why this proper concern about the rights of patients in clinical trials to be fully informed about the nature of the experiment, its expected benefits and its potential harms should not be extended to population experiments conducted in the name of health promotion or preventive medicine.
The ethical vacuum of preventive medicine At present, State or private bodies conducting mass preventive interventions have no obligation to inform the healthy participants that they are the subjects of experiments of uncertain outcome and potential harm. As the interventions are 'preventive medicine', they are automatically exempted from ethical constraints.
For example, in the Breast Cancer Detection Project set up in 1973 by the National Cancer Institute and the American Cancer Society to screen a quarter of a million healthy women, the possible risks of mammography were not explained to them nor were they told about the lack of evidence for the benefit of mammography in women under the age offifty (10 (14) .
The harm ofpreventive medicine has been discussed and documented by various authors (15) (16) (17) (18) . Even something so innocuous as the adoption of a cholesterol-lowering diet, as prescribed by the American Heart Association, could increase rather than decrease the risk of coronary heart disease in women (19) . The logical non-sequitur oflowering blood cholesterol in healthy people because cholesterol is a risk marker for coronary heart disease led to the tragedy of the clofibrate trial, in which significantly more healthy men treated with clofibrate died than the controls (12) . It is unlikely that the men were informed beforehand about the possibility that their participation in the trial might be harmful to them and even fatal.
As up to 50 per cent of a population (depending on an arbitrary definition of 'elevated' cholesterol) is the potential target for mass intervention by preventionists (20) , the pharmaceutical industry is eagerly anticipating the profits from the mountain of cholesterol-lowering medicaments which will be prescribed by doctors. Long-term effects of such treatment are not known but are unlikely to be harmless.
A similar situation exists in screening for hypertension. Hypertension is not a disease but an arbitrarily defined physical measure: not surprisingly, according to some 'experts', up to 40 per cent of adult populations are 'hypertensive'. The measurement of blood pressure in practice is uncertain and imprecise and consequently many people are labelled as 'hypertensive' on false grounds (21) . The effects of such labelling are serious: they include the erosion of the sense of well-being, lowered sense of self-esteem, marital problems, reduction in earning power, and the adoption of a 'sick role' in a previously healthy person (22) .
Women are particularly vulnerable to the exploits of preventive medicine. Great pressure is put on them to undergo regular gynaecological examinations, physical examinations oftheir breasts and to practise in addition breast self-examination. Some women doctors are starting to question the 'well-womanising' crusade, in which the major casualties are the women themselves (23) .
Breast cancer screening has an adverse harm-benefit ratio, but women are told nothing about the nature and the extent of risks; these include unnecessary operations due to false-positive results, which far outnumber true-positive findings (24,25). Schmidt Petr Skrabanek 189 calculated that for each woman who benefits from screening, 18 women have to live longer with the knowledge of their incurable disease ('extra cancer years') because of earlier diagnosis by screening. This estimate was based on the best mammographical results, which have not been reproduced in other centres. Schmidt also pointed out, in his detailed critique of the Swedish mammographic trial, that over 100 women would have needle biopsy and further surgical investigations for each woman who could expect benefit in terms of a cure (26) .
In cervical cancer screening, the possible benefits are debatable and may be non-existent, but the harms are common and largely ignored (27) . The principal author of the British National Health Programme, Alwyn Smith, stated that 'it is absurd to conduct a screening test in such a way that nearly forty women are referred for an expensive and possibly hazardous procedure for every woman who is at risk ofdeveloping serious disease' (28) . Yet this absurd situation continues unabated, without anyone recognising an obligation to the women to inform them about the true state of the 'art'.
Breast self-examination has never been shown to reduce mortality from breast cancer and there are theoretical reasons why it is unlikely to do so, because by the time breast cancer is palpable the tumour will have been growing for a long time. In the UK trial of early breast cancer detection this method was proved to be worthless (29) , and it could be argued that it is actually harmful, particularly in younger women, as it leads to unnecessary anxiety and unnecessary medical and surgical intervention in the vast majority ofwomen who discover an abnormality during the ritual of selfexamination (30) . Yet, as with other unproved preventive measures, cancer societies and other wellmeaning but misguided groups are allowed freely to broadcast misleading propaganda. Breast cancer screening recommendations were described by one editorialist as 'a confusing mixture of half-truths, unsupported by the scientific evidence to date, which only adds to the anxiety and uncertainty that always seems to cloud rational discussion of what knowledge we do -or especially do not -have about breast cancer' (31 In the absence of any ethical guidelines more and more unsuspecting people will be caught in the 'preventive' net.
In search of the ethics of preventive medicine Population interventions which have as their goal the prevention of coronary heart disease and many cancers should be classified as population experiments and the same guidelines should apply to them as to clinical trials. That such interventions are of an experimental nature and ofuncertain benefit is made clear by the fact that they are often tested in randomised controlled trials.
If a healthy volunteer, or a patient, has a right to be fully informed about the risks and benefits of the trial in which he takes part, even more meticulous attention should be paid to the rights of a whole population of healthy people who are subjected to mass prevention programmes and intervention, however well meant.
As Gillon pointed out, health education (and this applies equally to all areas ofpreventive medicine) is 'as heavily bedevilled by moral issues as is any other area of health care', and it should 'conform, as much as any other area of medical care, to the medico-moral norms of respect for people's autonomy, beneficence, nonmaleficence, and justice' (33) . In a penetrating analysis of the health-promotion industry, Williams noted that the field is riddled with serious conceptual and ethical problems, and expressed concern about the lack of protection of the public (by a medical equivalent of the Trades Description Act) against the hard-sell techniques of health salesmen (34) .
A forum should be set up enabling representatives of the public, and of the medical and legal professions, to identify the ethical problems posed by new developments in preventive medicine and health promotion. 
